Cargando…
Steroids or intravenous immunoglobulin as first line in MIS-C in LMICs
Autores principales: | Crosby, Laura, Balasubramanian, S, Ramanan, Athimalaipet V |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8302188/ https://www.ncbi.nlm.nih.gov/pubmed/34337437 http://dx.doi.org/10.1016/S2665-9913(21)00223-X |
Ejemplares similares
-
Immunoglobulin, glucocorticoid, or combined therapy for multisystem inflammatory syndrome in children
por: Chew, Christine, et al.
Publicado: (2023) -
COVID-19 in pregnancy: evidence from LMICs
por: Costa, Maria Laura, et al.
Publicado: (2022) -
Anakinra in Refractory Multisystem Inflammatory Syndrome in Children (MIS-C)
por: Bhat, Chandrika S., et al.
Publicado: (2021) -
Targeting hyperinflammation in infection: can we harness the COVID-19 therapeutics momentum to end the dengue drugs drought?
por: McBride, Angela, et al.
Publicado: (2021) -
Addressing fundamental questions on MIS-C
por: Davies, Patrick
Publicado: (2021)